Related Experiment Videos

Cutaneous malignant melanoma--clinical epidemiology and survival

M K Nair1, C Varghese, S Mahadevan

  • 1Regional Cancer Centre, Trivandrum.

Insights

Cutaneous malignant melanoma (CMM) is rare in Asia but has high mortality. This study of 79 Indian cases reveals a 5-year survival rate of 25.2%, highlighting challenges in diagnosis and treatment.

Area of Science:

  • Oncology
  • Epidemiology
  • Dermatology

Background:

  • Cutaneous malignant melanoma (CMM) incidence is low in Asian populations, with India reporting <0.5 per 1,000,000.
  • Despite low incidence, CMM in Asia presents significant mortality challenges due to diagnostic and management delays.

Purpose of the Study:

  • To present the clinical epidemiology and survival outcomes of 79 cutaneous malignant melanoma cases.
  • To analyze the impact of referral patterns and prior surgical interventions on CMM management and prognosis in India.

Main Methods:

  • Retrospective analysis of 79 CMM cases registered between 1985-1990 at a Regional Cancer Centre.
  • Evaluation of clinical data, including age, sex, referral patterns, and previous treatments, to assess epidemiological trends and survival rates.

Main Results:

  • The peak age incidence for CMM was observed in the 7th decade, with a male:female ratio of 1.6:1.
  • All cases received initial surgical treatment at peripheral centers, complicating accurate staging and definitive surgical planning.
  • The overall 5-year survival rate for CMM in this cohort was 25.2% (95% CI, 14%-38%).

Conclusions:

  • Cutaneous malignant melanoma in low-incidence regions like India presents unique epidemiological characteristics and survival challenges.
  • Inadequate referral patterns and initial management strategies significantly impact CMM staging and patient outcomes.
  • Further epidemiological studies are needed to understand the specific etiology and optimize management of CMM in Asian populations.

Related Concept Videos